“To recap here: The drug didn’t get any better, the cancer patients didn’t get any better, you just got better at making money, you just refined your skills at price gouging," charged the prosecutorial Katie Porter.
September 30, 2020

Rep. Katie Porter demanded to know why Celgene had increased the prices of a cancer drug over 300% in the past decade or so from the then CEO Mark Alles. His compensation increased as revenue increased.

Celgene was aquired by Bristol-Myers Squibb in 2019 for $95 billion, including debt. At the time, this was the largest pharmaceutical company acquisition ever.

Source: StatNews

A handful of newly elected Democrats, including Rashida Tlaib of Michigan, Ayanna Pressley of Massachusetts and Katie Porter of California put drug industry CEOs on the defensive Wednesday like they’ve never been before.

The trio of freshman lawmakers used an Oversight Committee hearing to press the CEOs of Teva, Celgene and Bristol-Myers Squibb — painfully and directly — on the results of an 18-month investigation into the pricing of two drugs: Teva’s Multiple Sclerosis drug copaxone and Bristol-Myers Squibb’s multiple myeloma drug revlimid.

Porter, a former consumer protection attorney who has made a name for herself by embarrassing CEOs with prosecutorial questions and a white board, lived up to her reputation. She used that white board to display Celgene’s repeated price hikes for revlimid, which now costs $763 per dose, up from $215 in 2005, and demanded that Mark Alles, who served as Celgene’s CEO until Bristol Myers Squibb acquired the company in 2019, on explain whether the drug had improved over the same time period.

When Alles tried to insist that the drug was approved for new indications, Porter pressed harder.

“Did the drug start to work faster? Were there fewer side effects? How did you change the formula or production of Revlimid to justify this price increase?” Porter said. “To recap here: The drug didn’t get any better, the cancer patients didn’t get any better, you just got better at making money, you just refined your skills at price gouging.”

And some reactions.

Can you help us out?

For 17 years we have been exposing Washington lies and untangling media deceit, but now Facebook is drowning us in an ocean of right wing lies. Please give a one-time or recurring donation, or buy a year's subscription for an ad-free experience. Thank you.

Discussion

We are currently migrating to Disqus

On May 14, 2022, we started migrating our comments from Insticator back to Disqus. During this transition period, some posts will have Insticator and some Disqus. For more information on the transition, as well as information regarding old C&L accounts, please see this post.


We welcome relevant, respectful comments. Any comments that are sexist or in any other way deemed hateful by our staff will be deleted and constitute grounds for a ban from posting on the site. Please refer to our Terms of Service for information on our posting policy.